Aurora Cannabis (ACB) Other Non-Current Assets (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Other Non-Current Assets of $2.6 million for Q1 2026, down 50.98% year-on-year from $5.4 million in Q1 2025, and down 23.49% on a QoQ basis from $3.4 million in Q4 2025.

Aurora Cannabis (ACB) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Other Non-Current Assets for 9 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Non-Current Assets fell 50.98% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 50.98% YoY) and the FY2026 annual result came in at $2.6 million, down 52.87% from the prior year.
  • Other Non-Current Assets declined to $2.6 million in Q1 2026 per ACB's latest filing, from $3.4 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ACB reached as high as $13.1 million in Q4 2022 and fell as low as $2.0 million in Q1 2022.
  • A 5-year average of $6.7 million and a median of $6.6 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 529.74% — and 2026, when it slumped 50.98%.
  • Year by year, Other Non-Current Assets stood at $13.1 million in 2022, then dropped by 26.89% to $9.5 million in 2023, then plunged by 31.32% to $6.6 million in 2024, then tumbled by 47.39% to $3.4 million in 2025, then retreated by 23.49% to $2.6 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.6 million, $3.4 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 2.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.64 Mn
Dec 31, 2025 3.45 Mn
Sep 30, 2025 4.10 Mn
Jun 30, 2025 4.70 Mn
Mar 31, 2025 5.38 Mn
Dec 31, 2024 6.56 Mn
Sep 30, 2024 7.43 Mn
Jun 30, 2024 8.10 Mn
Mar 31, 2024 8.93 Mn
Dec 31, 2023 9.54 Mn
Sep 30, 2023 10.24 Mn
Jun 30, 2023 11.87 Mn
Mar 31, 2023 11.68 Mn
Dec 31, 2022 13.05 Mn
Sep 30, 2022 2.19 Mn
Jun 30, 2022 2.47 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 2.07 Mn
Sep 30, 2021 2.69 Mn
Jun 30, 2021 2.88 Mn